These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1671812)

  • 21. Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin.
    Lee LT; Schally AV; Liebow C; Lee PP; Lee PH; Lee MT
    Anticancer Res; 2008; 28(5A):2599-605. PubMed ID: 19035284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Somatostatin and the digestive system. Clinical experiences].
    Herszényi L; Mihály E; Tulassay Z
    Orv Hetil; 2013 Sep; 154(39):1535-40. PubMed ID: 24058098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.
    Cives M; Strosberg J
    Drugs; 2015 May; 75(8):847-58. PubMed ID: 25911185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin analogs in the management of gastrointestinal tumors.
    Lamberts SW
    Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine tumours of the gastrointestinal tract. Biotherapy for metastatic endocrine tumours.
    Shah T; Caplin M
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):617-36. PubMed ID: 16183531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma.
    Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH
    J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic uses of somatostatin and its analogues: Current view and potential applications.
    Rai U; Thrimawithana TR; Valery C; Young SA
    Pharmacol Ther; 2015 Aug; 152():98-110. PubMed ID: 25956467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of somatostatin analogues in the treatment of gastro-enteropancreatic endocrine tumours.
    Bajetta E; Carnaghi C; Ferrari L; Spagnoli I; Mazzaferro V; Buzzoni R
    Digestion; 1996; 57 Suppl 1():72-6. PubMed ID: 8813475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the role of somatostatin analogs for the treatment of patients with gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis C; Caplin ME
    Semin Oncol; 2013 Feb; 40(1):56-68. PubMed ID: 23391113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field.
    Dalm VA; Hofland LJ; Lamberts SW
    Mol Cell Endocrinol; 2008 May; 286(1-2):262-77. PubMed ID: 17942217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When and How to Use Somatostatin Analogues.
    de Herder WW
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):549-555. PubMed ID: 30098715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules.
    Massironi S; Conte D; Rossi RE
    Scand J Gastroenterol; 2016; 51(5):513-23. PubMed ID: 26605828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
    Hofsli E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.
    de Herder WW; Lamberts SW
    Endocrine; 2003 Apr; 20(3):285-90. PubMed ID: 12721509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.
    Igarashi H; Hijioka M; Lee L; Ito T
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):618-22. PubMed ID: 25689143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin analogue treatment of neuroendocrine tumours.
    de Herder WW; van der Lely AJ; Lamberts SW
    Postgrad Med J; 1996 Jul; 72(849):403-8. PubMed ID: 8935599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic use of somatostatin analogues in endocrinology].
    Faglia G; Arosio M
    Recenti Prog Med; 1992 Nov; 83(11):626-33. PubMed ID: 1363150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic hormones and cancer.
    Schally AV; Comaru-Schally AM; Nagy A; Kovacs M; Szepeshazi K; Plonowski A; Varga JL; Halmos G
    Front Neuroendocrinol; 2001 Oct; 22(4):248-91. PubMed ID: 11587553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.